Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitals

Mohamedraed Elshami, Lauryn Bailey, Richard S. Hoehn, John B. Ammori, Jeffrey M. Hardacre, J. Eva Selfridge, David Bajor, Amr Mohamed, Sakti Chakrabarti, Amit Mahipal, Jordan M. Winter, Lee M. Ocuin

Research output: Contribution to journalArticlepeer-review

Abstract

Background: We examined differences in surgical intervention at minority-serving hospitals versus non-minority-serving hospitals among patients with early-stage hepatocellular carcinoma. We also investigated associations between surgical management and overall survival, stratified by minority-serving hospital status. Methods: Patients with early-stage hepatocellular carcinoma, defined as cT1, were identified within the National Cancer Database (2004–2018). The primary outcome was surgical intervention (resection, ablation, or transplantation). The proportion of minority (non-Hispanic Black or Hispanic) patients treated at each facility was determined, and hospitals in the top decile were considered minority-serving hospitals. Results: A total of 46,703 patients with early-stage hepatocellular carcinoma were identified, of whom 4,214 (9.0%) were treated at minority-serving hospitals. Patients treated at minority-serving hospitals were less likely to undergo surgical intervention than patients treated at non-minority-serving hospitals (odds ratio = 0.87, 95% confidence interval: 0.81–0.94). Minority patients treated at non-minority-serving hospitals were less likely to undergo surgical intervention than White patients (odds ratio = 0.86, 95% confidence interval: 0.82–0.90) and had a further associated decrease in the likelihood of surgical intervention when treated at minority-serving hospitals (odds ratio = 0.81, 95% confidence interval: 0.69–0.94). Regardless of minority-serving hospital status, surgery was associated with improved overall survival. There were no clinically meaningful differences in overall survival between White and minority patients who underwent surgery either at minority-serving hospitals or non-minority-serving hospitals. Conclusions: Patients with early-stage hepatocellular carcinoma had an associated decrease in the likelihood of surgical intervention when treated at minority-serving hospitals. Minority patients treated at minority-serving hospitals had an associated decrease in the likelihood of surgery, but to a lesser extent when treated at non-minority-serving hospitals. Surgery was associated with improved overall survival regardless of minority or minority-serving hospital status.

Original languageEnglish (US)
Pages (from-to)1201-1207
Number of pages7
JournalSurgery (United States)
Volume174
Issue number5
DOIs
StatePublished - Nov 2023

ASJC Scopus subject areas

  • Surgery

Fingerprint

Dive into the research topics of 'Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitals'. Together they form a unique fingerprint.

Cite this